Neuroimaging Biomarkers of mTOR Inhibition on Vascular and Metabolic Functions in Aging Brain and Alzheimer’s Disease
The mechanistic target of rapamycin (mTOR) is a nutrient sensor of eukaryotic cells. Inhibition of mechanistic mTOR signaling can increase life and health span in various species via interventions that include rapamycin and caloric restriction (CR). In the central nervous system, mTOR inhibition dem...
Main Authors: | Jennifer Lee, Lucille M. Yanckello, David Ma, Jared D. Hoffman, Ishita Parikh, Scott Thalman, Bjoern Bauer, Anika M. S. Hartz, Fahmeed Hyder, Ai-Ling Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnagi.2018.00225/full |
Similar Items
-
The mTOR–Autophagy Axis and the Control of Metabolism
by: Nerea Deleyto-Seldas, et al.
Published: (2021-07-01) -
Judicious Toggling of mTOR Activity to Combat Insulin Resistance and Cancer: Current Evidence and Perspectives
by: Pei Shi Ong, et al.
Published: (2016-10-01) -
APOE genotype-dependent pharmacogenetic responses to rapamycin for preventing Alzheimer's disease
by: Ai-Ling Lin, et al.
Published: (2020-06-01) -
Low Concentration of Rapamycin Inhibits Hemangioma Endothelial Cell Proliferation, Migration, and Vascular Tumor Formation in Mice
by: Ningning Zheng, PhD, et al.
Published: (2014-12-01) -
mTOR-dependent dysregulation of autophagy contributes to the retinal ganglion cell loss in streptozotocin-induced diabetic retinopathy
by: Sanjar Batirovich Madrakhimov, et al.
Published: (2021-02-01)